Abstract: A novel fused pyrimidine based sulfonamide derivative represented by Formula I, a solvate thereof, or a pharmaceutically acceptable salt thereof, and a pharmaceutical composition including the same as an active ingredient are disclosed. The novel fused pyrimidine based sulfonamide derivative can effectively suppress the growth of cancer cells and resistance to drugs, which are induced by mutations in the tyrosine kinase domain of epidermal growth factor receptors, or the growth of cancer cells having such resistance.

Abstract: Disclosed is a bus stop using a large-scale perovskite solar cell in which a perovskite solar cell is prepared using a hybrid structure including a graphene-carbon nanotube. The bus stop includes a body unit fixed to the ground to maintain the overall shape, a solar cell unit for producing electrical energy from sunlight, and an energy storage system (ESS) for storing the electrical energy produced by the solar cell part.

Abstract: Disclosed is a bus stop using a large-scale perovskite solar cell in which a perovskite solar cell is prepared using a hybrid structure including a graphene-carbon nanotube. The bus stop includes a body unit fixed to the ground to maintain the overall shape, a solar cell unit for producing electrical energy from sunlight, and an energy storage system (ESS) for storing the electrical energy produced by the solar cell part.

Abstract: Disclosed herein is a dishwasher including a main body provided with an open hole and a washing tub; a door configured to open or close the open hole; a door opening/closing member configured to open or close the open hole; an air curtain disposed in the main body, to operate a fan such that ambient air is sucked and the sucked air is discharged; a detector configured to detect information of the fan; and a controller configured to diagnose the failure of the fan based on the detected information of the fan, to control an operation of the door opening/closing member such that the door is opened at a predetermined open time and an open time of the door is delayed when the fan is a failure state, and to control an operation of the fan when the fan is a normal state during a drying operation.

Abstract: The present disclosure relates to a deglycosylated antibody binding specifically to C-type lectin domain family 14, member A (clec14a). More particularly, the present disclosure relates to a deglycosylated antibody that comprises a light chain variable region comprising CDR1 having a certain sequence and binds specifically to clec14, and use thereof, for example, a pharmaceutical composition containing the antibody for preventing or treating an angiogenesis-related disease.

Abstract: The present invention relates to a dishwasher and a method for controlling same, and the dishwasher may comprise a wash tub having an opening on at least one side thereof; a spray nozzle, provided in the interior of the wash tub, for spraying wash water; a reflecting module capable of moving in the interior of the wash tub, and reflecting the wash water sprayed by the spray nozzle; and a moving module, to which the reflecting module is detachably attached, for moving same in at least one direction.

Abstract: Disclosed herein is a dishwasher including a main body provided with an open hole and a washing tub; a door configured to open or close the open hole; a door opening/closing member configured to open or close the open hole; an air curtain disposed in the main body, to operate a fan such that ambient air is sucked and the sucked air is discharged; a detector configured to detect information of the fan; and a controller configured to diagnose the failure of the fan based on the detected information of the fan, to control an operation of the door opening/closing member such that the door is opened at a predetermined open time and an open time of the door is delayed when the fan is a failure state, and to control an operation of the fan when the fan is a normal state during a drying operation.

Abstract: A liquid crystal display device includes a liquid crystal panel including first and second substrates and a liquid crystal layer between the first and second substrates; a backlight unit under the liquid crystal panel; a bottom frame including a horizontal surface and first, second, third, and fourth side surfaces, the first side surface corresponding to a first edge of the liquid crystal panel and being opposite to the second side surface, wherein the liquid crystal panel has a size larger than the bottom frame such that a side of the liquid crystal panel protrudes beyond the bottom frame; a main frame including a first guide portion corresponding to the first edge and a second guide portion corresponding a second edge of the liquid crystal panel opposite to the first edge; and an adhesive covering the side of the liquid crystal panel and an outer side of the third and fourth side surfaces.

Abstract: The present invention relates to a dishwasher and a method for controlling same, and the dishwasher may comprise a wash tub having an opening on at least one side thereof; a spray nozzle, provided in the interior of the wash tub, for spraying wash water; a reflecting module capable of moving in the interior of the wash tub, and reflecting the wash water sprayed by the spray nozzle; and a moving module, to which the reflecting module is detachably attached, for moving same in at least one direction.

Abstract: A liquid crystal display device includes a liquid crystal panel including first and second substrates and a liquid crystal layer between the first and second substrates; a backlight unit under the liquid crystal panel; a bottom frame including a horizontal surface and first, second, third, and fourth side surfaces, the first side surface corresponding to a first edge of the liquid crystal panel and being opposite to the second side surface, wherein the liquid crystal panel has a size larger than the bottom frame such that a side of the liquid crystal panel protrudes beyond the bottom frame; a main frame including a first guide portion corresponding to the first edge and a second guide portion corresponding a second edge of the liquid crystal panel opposite to the first edge; and an adhesive covering the side of the liquid crystal panel and an outer side of the third and fourth side surfaces.

Abstract: A novel fused pyrimidine derivative has an inhibitory activity for tyrosine kinases. A pharmaceutical composition for preventing or treating cancers, tumors, inflammatory diseases, autoimmune diseases, or immunologically mediated diseases contains the fused pyrimidine derivative as an active ingredient.

Abstract: A liquid crystal display device includes a liquid crystal panel including first and second substrates and a liquid crystal layer between the first and second substrates; a backlight unit under the liquid crystal panel; a bottom frame including a horizontal surface and first, second, third, and fourth side surfaces, the first side surface corresponding to a first edge of the liquid crystal panel and being opposite to the second side surface, wherein the liquid crystal panel has a size larger than the bottom frame such that a side of the liquid crystal panel protrudes beyond the bottom frame; a main frame including a first guide portion corresponding to the first edge and a second guide portion corresponding a second edge of the liquid crystal panel opposite to the first edge; and an adhesive covering the side of the liquid crystal panel and an outer side of the third and fourth side surfaces.

Abstract: The present invention relates to a novel fused pyrimidine derivative having an inhibitory activity for tyrosine kinases, and a pharmaceutical composition for preventing or treating cancers, tumors, inflammatory diseases, autoimmune diseases, or immunologically mediated diseases comprising same as an active ingredient.

Abstract: A polymer electrolyte including a polymer fiber having a nanoscale diameter, wherein the polymer fiber is fabricated by an electrospinning method and a solar cell device exhibiting high energy conversion efficiency using the same. The solid-state electrolyte comprising such nanosized polymer fiber does not need a sealing agent and further simplifies the entire process compared to a conventional dye-sensitized solar cell using liquid electrolytes. Specifically, the energy conversion efficiency of the present dye-sensitized solar cell is significantly superior to that of a dye-sensitized solar cell using a polymer film electrolyte fabricated by a spin coating method. Further, the present dye-sensitized solar cell device can be obtained by using a scattering layer and compensating the surface effect.

Abstract: A liquid crystal display device includes a liquid crystal panel including first and second substrates and a liquid crystal layer between the first and second substrates; a backlight unit under the liquid crystal panel; a bottom frame including a horizontal surface and first, second, third, and fourth side surfaces, the first side surface corresponding to a first edge of the liquid crystal panel and being opposite to the second side surface, wherein the liquid crystal panel has a size larger than the bottom frame such that a side of the liquid crystal panel protrudes beyond the bottom frame; a main frame including a first guide portion corresponding to the first edge and a second guide portion corresponding a second edge of the liquid crystal panel opposite to the first edge; and an adhesive covering the side of the liquid crystal panel and an outer side of the third and fourth side surfaces.

Abstract: The present invention relates to a novel fused pyrimidine derivative having an inhibitory activity for tyrosine kinases, and a pharmaceutical composition for preventing or treating cancers, tumors, inflammatory diseases, autoimmune diseases, or immunologically mediated diseases comprising same as an active ingredient.

Abstract: The present invention relates to a novel fused pyrimidine derivative having an inhibitory activity for tyrosine kinases, and a pharmaceutical composition for preventing or treating cancers, tumors, inflammatory diseases, autoimmune diseases, or immunologically mediated diseases comprising same as an active ingredient.

Abstract: The present invention relates to a novel fused pyrimidine derivative having an inhibitory activity for tyrosine kinases, and a pharmaceutical composition for preventing or treating cancers, tumors, inflammatory diseases, autoimmune diseases, or immunologically mediated diseases comprising same as an active ingredient.

Abstract: The present invention provides a novel amide derivative of formula (I) and a pharmaceutically acceptable salt thereof, and a pharmaceutical composition comprising same as an active ingredient.

Abstract: The present invention relates to a novel fused pyrimidine derivative having an inhibitory activity for tyrosine kinases, and a pharmaceutical composition for preventing or treating cancers, tumors, inflammatory diseases, autoimmune diseases, or immunologically mediated diseases comprising same as an active ingredient.